Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B G Johnson

Showing results (51-60 of 74) with videos related to

Pageof 8
Sort By:
Journal of Medicinal Chemistry|July 22, 1994
Discovery of a potent, peripherally selective trans-3,4-dimethyl-4-(3-hydroxyphenyl)piperidine opioid antagonist for the treatment of gastrointestinal motility disordersD M Zimmerman, J S Gidda, B E Cantrell, et al.
Journal of Neuroscience Methods|June 1, 1995
Second-messenger responses in brain slices to elucidate novel glutamate receptorsD D Schoepp, B G Johnson, C R Salhoff, et al.
Journal of Medicinal Chemistry|February 17, 1998
2-Substituted (2SR)-2-amino-2-((1SR,2SR)-2-carboxycycloprop-1-yl)glycines as potent and selective antagonists of group II metabotropic glutamate receptors. 1. Effects of alkyl, arylalkyl, and diarylalkyl substitutionP L Ornstein, T J Bleisch, M B Arnold, et al.
Brain Research Bulletin|December 1, 1988
Mediation of serotonin-induced analgesia by the 5HT2 receptor in the pentobarbital anesthetized mouse modelW A Banks, A J Kastin, T L Trentman, et al.
Journal of Dental Education|June 1, 1980
Providing preventive dental care in the community using the team approach: a comparison of five training programsJ A Balzer, D V Kleinman, R C Graves, et al.
Neuropharmacology|October 26, 1999
[3H]-LY341495 as a novel antagonist radioligand for group II metabotropic glutamate (mGlu) receptors: characterization of binding to membranes of mGlu receptor subtype expressing cellsB G Johnson, R A Wright, M B Arnold, et al.
Bioorganic & Medicinal Chemistry Letters|January 5, 1999
Synthesis and metabotropic glutamate receptor antagonist activity of N1-substituted analogs of 2R,4R-4-aminopyrrolidine-2,4-dicarboxylic acidM J Valli, D D Schoepp, R A Wright, et al.
Bioorganic & Medicinal Chemistry Letters|January 1, 1999
(2S,4S)-amino-4-(2,2-diphenylethyl)pentanedioic acid selective group 2 metabotropic glutamate receptor antagonistA Escribano, J Ezquerra, C Pedregal, et al.
Journal of Medicinal Chemistry|February 16, 1996
(2S,4S)-2-amino-4-(4,4-diphenylbut-1-yl)- pentane-1,5-dioic acid: a potent and selective antagonist for metabotropic glutamate receptors negatively linked to adenylate cyclaseC G Wermuth, A Mann, A Schoenfelder, et al.
Journal of Medicinal Chemistry|October 1, 1993
Structure-activity relationships of trans-3,4-dimethyl-4-(3-hydroxyphenyl)piperidine antagonists for mu- and kappa-opioid receptorsD M Zimmerman, J D Leander, B E Cantrell, et al.
Pageof 8

Showing results (51-60 of 74) with videos related to

Sort By:
Pageof 8
Journal of Medicinal Chemistry|July 22, 1994
Discovery of a potent, peripherally selective trans-3,4-dimethyl-4-(3-hydroxyphenyl)piperidine opioid antagonist for the treatment of gastrointestinal motility disordersD M Zimmerman, J S Gidda, B E Cantrell, et al.
Journal of Neuroscience Methods|June 1, 1995
Second-messenger responses in brain slices to elucidate novel glutamate receptorsD D Schoepp, B G Johnson, C R Salhoff, et al.
Journal of Medicinal Chemistry|February 17, 1998
2-Substituted (2SR)-2-amino-2-((1SR,2SR)-2-carboxycycloprop-1-yl)glycines as potent and selective antagonists of group II metabotropic glutamate receptors. 1. Effects of alkyl, arylalkyl, and diarylalkyl substitutionP L Ornstein, T J Bleisch, M B Arnold, et al.
Brain Research Bulletin|December 1, 1988
Mediation of serotonin-induced analgesia by the 5HT2 receptor in the pentobarbital anesthetized mouse modelW A Banks, A J Kastin, T L Trentman, et al.
Journal of Dental Education|June 1, 1980
Providing preventive dental care in the community using the team approach: a comparison of five training programsJ A Balzer, D V Kleinman, R C Graves, et al.
Neuropharmacology|October 26, 1999
[3H]-LY341495 as a novel antagonist radioligand for group II metabotropic glutamate (mGlu) receptors: characterization of binding to membranes of mGlu receptor subtype expressing cellsB G Johnson, R A Wright, M B Arnold, et al.
Bioorganic & Medicinal Chemistry Letters|January 5, 1999
Synthesis and metabotropic glutamate receptor antagonist activity of N1-substituted analogs of 2R,4R-4-aminopyrrolidine-2,4-dicarboxylic acidM J Valli, D D Schoepp, R A Wright, et al.
Bioorganic & Medicinal Chemistry Letters|January 1, 1999
(2S,4S)-amino-4-(2,2-diphenylethyl)pentanedioic acid selective group 2 metabotropic glutamate receptor antagonistA Escribano, J Ezquerra, C Pedregal, et al.
Journal of Medicinal Chemistry|February 16, 1996
(2S,4S)-2-amino-4-(4,4-diphenylbut-1-yl)- pentane-1,5-dioic acid: a potent and selective antagonist for metabotropic glutamate receptors negatively linked to adenylate cyclaseC G Wermuth, A Mann, A Schoenfelder, et al.
Journal of Medicinal Chemistry|October 1, 1993
Structure-activity relationships of trans-3,4-dimethyl-4-(3-hydroxyphenyl)piperidine antagonists for mu- and kappa-opioid receptorsD M Zimmerman, J D Leander, B E Cantrell, et al.
Pageof 8